HFE H63D-mediated Bip activation is sensitive to ER stress inhibitors. Representative Western blots are shown in A and C. The results of three trials are shown in graphic form in B and D (HFE WT in A and B; H63D in C and D). Cells were induced with tetracycline for 1 day and then exposed to one of the following treatments. Dimethyl sulfoxide (DMSO; vehicle control for TM), 1 μg/ml tunicamycin in dimethyl sulfoxide (TM), or TUDCA in culture medium at 2 mm (TA2) or at 10 mm (TA10) in the presence of tetracycline (tet) for 30 h. Equal amounts of proteins from cell lysates were subject to immunoblot to monitor the expression levels of FLAG-HFE, Bip, and actin. Bip expression was normalized by actin and calculated as the ratio to the control conditions: (+tet) in WT and (−tet) in H63D. The blots in each panel came from the same gel. Dividing lines were used to show the different parts of the same gel. A and B, WT HFE expressing cells: lane 1 (tet), expression of WT HFE protein; lane 2 (tet+DMSO), vehicle control for TM; lane 3 (tet+TM), TM treatment increased Bip; lane 4 and 5 (tet+TM+TA2 and +TA10): reverse Bip increase by ER stress inhibitor TA in a concentration-dependent manner. C and D, HFE H63D expressing cells: lane 1 (−tet), uninduced cell control; lane 2 (tet), induced HFE H63D expression increased Bip; lane 3 (tet+TA10), increased Bip with H63D induction is reduced by TA. In addition to the effects on Bip, decreased expression of HFE-FLAG can be observed under TM treatment: A, lane 3 (tet+TM) and C, lane 5 (tet+TM), which could be reversed by TA, A, lane 5 (tet+TM+TA10). **, p < 0.05; ***, p < 0.001 (n = 3).